Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis (Q38757160)

6 September 2017

0 references

Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis (English)

1 reference

6 September 2017

1 reference

1 reference

Erin Cordeiro

1

1 reference

6 September 2017

Mai-Kim Gervais

2

1 reference

6 September 2017

Prakesh S Shah

3

1 reference

6 September 2017

Nicole J Look Hong

4

1 reference

6 September 2017

Frances C Wright

5

1 reference

6 September 2017

publication date

1 March 2016

1 reference

Annals of Surgical Oncology

6 September 2017

published in

1 reference

6 September 2017

volume

23

1 reference

6 September 2017

issue

13

1 reference

6 September 2017

page(s)

4178-4188

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-016-5137-z

6 September 2017

exact match

0 references

cites work

Emerging trends in the epidemiology of melanoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Complications associated with sentinel lymph node biopsy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Melanoma, version 4.2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

U.K. guidelines for the management of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

The correlation of regression in primary melanoma with sentinel lymph node status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Analysis of sentinel lymph node positivity in patients with thin primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Lessons learned from the Sunbelt Melanoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph nodes study in 30 cases of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy in patients with thin melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel node biopsy for melanoma: a study of 241 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy in patients with thin melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy for melanoma in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Outcomes and prognostic factors in superficial spreading melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Correlation of histologic regression in primary melanoma with sentinel node status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5137-Z

10.1245/S10434-016-5137-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1009006822

0 references

1 reference